Navigation Links
China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
Date:5/28/2009

HARBIN, China, May 28 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that Mr. Hubert Cooleman, Flemish economic representative for the North of the PRC and Mongolia, visited Harbin Tian Di Ren Medical Company ("TDR"), a wholly-owned subsidiary of China Sky One, in Harbin on May 26, 2009.

China Sky One management presented and discussed the Company's recent developments with Mr. Cooleman, including its strong product portfolio, its expanded international sales network, and its ongoing research and development projects. In his capacity as economic representative for the North of the PRC, Mr. Cooleman provided suggestions for expanding into Belgium, one of the most advanced countries in the field of biomedical engineering, in order to strengthen ties with the Chinese market.

At the end of the Company's meeting with Mr. Cooleman, a tentative business proposal was reached, which served as a memorandum for the efforts of all parties involved in the discussions. This covered a number of areas, including market entry into both Belgium and China as well as research and development cooperation between both countries. Ms. Xiao-yan Han, Vice Chairman and COO of China Sky One, and Mr. Stanley Hao, CFO of China Sky One, as well as Directors in the international business and research and development departments of the Company, joined the meeting.

"We appreciate Mr. Cooleman's visit to China Sky One and his efforts to help build strong working relationships and a bridge between companies in our two countries," said Ms. Xiao-yan Han, Vice Chairman and COO of China Sky One Medical. "We will continue this dialogue and explore more opportunities in Europe, including international trade and science and technology cooperation opportunities.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com.

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding international cooperation. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    Company Contact:                         Investor Relations Contact:
    China Sky One Medical, Inc.              CCG Investor Relations
    Mr. Stanley Hao, CFO                     Mr. Crocker Coulson, President
    Tel: +86-0451-53994069                   Tel: +1-646-213-1915
    Email: china_sky_one@yahoo.cn             Email: crocker.coulson@ccgir.com
                                             Website: www.ccgirasia.com


'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Nepstar Chain Drugstore Reports First Quarter 2009 Financial Results
2. China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F
3. China Kangtai Cactus Biotech Announces Goal to Expand and Enhance Shareholder Communication
4. Frost & Sullivan Looks at the Influence of Chinas New Health Reform on the Pharmaceutical Market
5. NSD Bio Group, LLC Selected By U.S. - China Economic & Security Review Commission for Analysis of Chinas Pharma Supply Chain on U.S. Pharmaceuticals
6. China Medicine Corporation Holds Annual General Meeting of Shareholders
7. China Shenghuo Reports Unaudited Financial Results for the First Quarter of 2009
8. China Medicine Wins Best 1000 SME Award in Guangdong Province; Eligible for RMB 25 Million Loan
9. China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates
10. China and the Netherlands join forces for research into water management
11. China Sky One Medical, Inc. Announces Record First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish ... take advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional ... appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity ...
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just brushing ... inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. , ... bad techniques of brushing the teeth in order to prevent cavities," he said. "Children ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... OSWEGO, Ore. , Dec. 5, 2016   ... the BioInsight clinical study. The study evaluates the safety ... insertion procedure in an office setting. BioMonitor ... ® technology that is placed underneath a patient,s ... fibrillation and syncope (fainting). Atrial fibrillation is a leading ...
(Date:12/5/2016)... PITTSBURGH , Dec. 5, 2016  Wellbridge Health and ... innovative digital health solutions to Medicare and Medicaid plan members ... effort targeted at the unique needs of this group of ... on social work philosophies to provide insight into members, daily ... , ...
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
Breaking Medicine Technology: